Medicamen Organics IPO price band announced: All you need to know about ₹10.5-crore public issue

The price band for Medicamen Organics Limited’s Initial Public Offer (IPO) has been finalised. The NSE SME IPO is set to open for subscription on Friday, June 21.

Medicamen Organics IPO price band has been fixed at ₹32 to ₹34 per share.

Here are the key details about the public issue you should know before bidding.

Medicamen Organics IPO offer size

Medicamen Organics IPO is a book-building issue worth ₹10.54 crore. The public offer comprises entirely a fresh issue of 31 lakh shares. The company has reserved 50% of the net issue for Qualified Institutional Buyers (QIB), 35% of the issue has been reserved for retail shares and 15% of the issue has been reserved for Non-Institutional Investors (NIIs).

Medicamen Organics IPO lot size and minimum investment

The minimum lot size for investing in Medicamen Organics IPO for retail investors is 1 lot comprising 4000 shares, which translates to an investment of ₹1,36,000. High Net-Worth Individuals can bid for 2 lots of 8,000 shares, aggregating to ₹2,72,000.

Medicamen Organics IPO subscription, allotment status and listing date

The subscription window for Medicamen Organics IPO will open on Friday, June 21, and close on Tuesday, June 25. The IPO share allotment status will be finalised by Wednesday, June 26. Refunds will be issued for unsuccessful bidders and successful bidders will receive shares in their demat accounts on June 27.

Shares of Medicamen Organics will be listed on the NSE SME platform, Emerge, with the tentative listing date fixed as June 28.

Medicamen Organics Limited IPO registrar

The book running lead manager for the issue is GYR Capital Advisors Private Limited and the registrar for the issue is Kfin Technologies Limited.

Medicamen Organics Limited IPO financials

For the six month period ended September 30, 2023, Medicamen Organics posted a revenue of ₹11.32 crore while the company’s net worth for the same period stood at ₹11.8 crore and Profit After Tax (PAT) was ₹1.29 crore.

The pharmaceutical company’s revenue for FY23 increased over 8% to ₹22.96 crore against ₹21.18 crore in FY22. The company’s net worth grew nearly 13% to ₹8.51 crore from ₹7.55 crore on a year-on-year basis. The company’s net profit surged nearly 938% to ₹95.78 lakh in FY23 from ₹9.23 lakh in the preceding fiscal.

Medicamen Organics Limited promoters

The promoter of the company is Bal Kishan Gupta and he holds 81.21% stake in the company pre-issue.

Medicamen Organics Limited IPO objective

The company will use the money raised via the public issue for funding expenses for product registration in the international markets. The company will also use a portion of the IPO proceeds for updating its plant and increasing production facility. The pharmaceutical company will also use the money for meeting its working capital needs.

About Medicamen Organics Limited

Medicamen Organics Ltd is a developer, manufacturer and distributor of pharmaceutical dosages. The company’s product portfolio includes tablets, capsules, oral liquids, ointments, gels, syrups, suspensions and dry powders. The pharma company works as a contract manufacturer,, or third party manufacturer, for state and central governments as well as private entities.

To know more about IPOs listing, schedule and upcoming IPOs, click here